Skip to main content
British Heart Journal logoLink to British Heart Journal
. 1965 Jul;27(4):520–526. doi: 10.1136/hrt.27.4.520

EVALUATION OF FOUR DIFFERENT SERUM ENZYMES IN THE DIAGNOSIS OF ACUTE MYOCARDIAL INFARCTION

Nis I Nissen 1, P Ranløv 1, J Weis-fogh 1
PMCID: PMC503341  PMID: 14324110

Full text

PDF
520

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. COLOMBO J. P., RICHTERICH R., ROSSI E. [Serum creatine phosphokinase: determination and diagnostic significance]. Klin Wochenschr. 1962 Jan 1;40:37–44. doi: 10.1007/BF01483449. [DOI] [PubMed] [Google Scholar]
  2. DREYFUS J. C., SCHAPIRA G., RESNAIS J., SCEBAT L. [Serum creatine kinase in the diagnosis of myocardial infarct]. Rev Fr Etud Clin Biol. 1960 Apr;5:386–387. [PubMed] [Google Scholar]
  3. DRIVSHOLM A., MADSEN S. The influence of treatment with sodium salicylate on the serum glutamic oxalacetic transaminase activity. Scand J Clin Lab Invest. 1961;13:442–446. [PubMed] [Google Scholar]
  4. ELLIOTT B. A., WILKINSON J. H. Serum "alpha-hydroxybutyric dehydrogenase" in myocardial infarction and in liver disease. Lancet. 1961 Apr 1;1(7179):698–699. doi: 10.1016/s0140-6736(61)91724-x. [DOI] [PubMed] [Google Scholar]
  5. FORSTER G., ESCHER J. [Creatine phosphokinase in the diagnosis of myocardial infarction and myopathies]. Helv Med Acta. 1961 Sep;28:513–519. [PubMed] [Google Scholar]
  6. HENLEY K. S., POLLARD H. M. A new method for the determination of glutamic oxalacetic and glutamic pyruvic transaminase in plasma. J Lab Clin Med. 1955 Nov;46(5):785–789. [PubMed] [Google Scholar]
  7. HUGHES B. P. A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera. Clin Chim Acta. 1962 Sep;7:597–603. doi: 10.1016/0009-8981(62)90137-7. [DOI] [PubMed] [Google Scholar]
  8. KONTTINEN A., HALONEN P. I. Serum alpha-hydroxybutyric dehydrogenase (HBD) in myocardial infarction. Comparison with glutamic oxalacetic transminase (GOT) and lactic dehydrogenase (LDH). Am J Cardiol. 1962 Oct;10:525–531. doi: 10.1016/0002-9149(62)90377-6. [DOI] [PubMed] [Google Scholar]
  9. LADUE J. S., WROBLEWSKI F., KARMEN A. Serum glutamic oxaloacetic transaminase activity in human acute transmural myocardial infarction. Science. 1954 Sep 24;120(3117):497–499. doi: 10.1126/science.120.3117.497. [DOI] [PubMed] [Google Scholar]
  10. MOLLER C. E., RAABO E. DIAGNOSTIC USE OF FRACTIONATED LACTIC DEHYDROGENASE ACTIVITY (LDH) IN MYOCARDIAL INFARCTION. Acta Med Scand. 1964 Jan;175:31–42. doi: 10.1111/j.0954-6820.1964.tb00547.x. [DOI] [PubMed] [Google Scholar]
  11. PAGLIARO L., NOTARBARTOLO A. Alpha-Hydroxybutyric dehydrogenase in the diagnosis of myocardial infarction. Lancet. 1962 May 19;1(7238):1043–1045. doi: 10.1016/s0140-6736(62)92144-x. [DOI] [PubMed] [Google Scholar]
  12. ROSALKI S. B., WILKINSON J. H. Reduction of alpha-ketobutyrate by human serum. Nature. 1960 Dec 24;188:1110–1111. doi: 10.1038/1881110a0. [DOI] [PubMed] [Google Scholar]
  13. SCEBAT L., RENAIS J., LENEGRE J. [Serum creatine-kinase in the diagnosis of myocardial lesions. (Clinical and experimental study)]. Arch Mal Coeur Vaiss. 1961 Jul;54:721–731. [PubMed] [Google Scholar]
  14. SCHNEIDER K. W., HEISE E. R. [Diagnostic significance of increased creatine phosphokinase activity in the blood]. Dtsch Med Wochenschr. 1963 Mar 15;88:520–525. doi: 10.1055/s-0028-1111974. [DOI] [PubMed] [Google Scholar]
  15. SORENSEN N. S. CREATINE PHOSPHOKINASE IN THE DIAGNOSIS OF MYOCARDIAL INFARCTION. Acta Med Scand. 1963 Dec;174:725–734. [PubMed] [Google Scholar]
  16. TANZER M. L., GILVARG C. Creatine and creatine kinase measurement. J Biol Chem. 1959 Dec;234:3201–3204. [PubMed] [Google Scholar]
  17. WROBLEWSKI F., LADUE J. S. Lactic dehydrogenase activity in blood. Proc Soc Exp Biol Med. 1955 Oct;90(1):210–213. doi: 10.3181/00379727-90-21985. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES